Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE ε4 variant.

Burggren AC, Mahmood Z, Harrison TM, Siddarth P, Miller KJ, Small GW, Merrill DA, Bookheimer SY.

Alzheimers Dement. 2017 Jul;13(7):739-748. doi: 10.1016/j.jalz.2016.12.009. Epub 2017 Feb 7.

PMID:
28183529
2.

Assessment of in-vitro cholinesterase inhibitory and thrombolytic potential of bark and seed extracts of Tamarindus indica (L.) relevant to the treatment of Alzheimer's disease and clotting disorders.

Biswas K, Azad AK, Sultana T, Khan F, Hossain S, Alam S, Chowdhary R, Khatun Y.

J Intercult Ethnopharmacol. 2017 Jan 3;6(1):115-120. doi: 10.5455/jice.20161229055750. eCollection 2017 Jan-Mar.

3.

Reduced thermal sensitivity and increased opioidergic tone in the TASTPM mouse model of Alzheimer's disease.

Aman Y, Pitcher T, Simeoli R, Ballard C, Malcangio M.

Pain. 2016 Oct;157(10):2285-96. doi: 10.1097/j.pain.0000000000000644.

4.

Loss of presenilin function is associated with a selective gain of APP function.

Deyts C, Clutter M, Herrera S, Jovanovic N, Goddi A, Parent AT.

Elife. 2016 May 19;5. pii: e15645. doi: 10.7554/eLife.15645.

5.

The Effect of a High-Fat Diet on Brain Plasticity, Inflammation and Cognition in Female ApoE4-Knockin and ApoE-Knockout Mice.

Janssen CI, Jansen D, Mutsaers MP, Dederen PJ, Geenen B, Mulder MT, Kiliaan AJ.

PLoS One. 2016 May 12;11(5):e0155307. doi: 10.1371/journal.pone.0155307. eCollection 2016.

6.

Multimodal Brain Imaging Reveals Structural Differences in Alzheimer's Disease Polygenic Risk Carriers: A Study in Healthy Young Adults.

Foley SF, Tansey KE, Caseras X, Lancaster T, Bracht T, Parker G, Hall J, Williams J, Linden DE.

Biol Psychiatry. 2017 Jan 15;81(2):154-161. doi: 10.1016/j.biopsych.2016.02.033. Epub 2016 Mar 16.

7.
8.

Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease.

Ferreira ST, Lourenco MV, Oliveira MM, De Felice FG.

Front Cell Neurosci. 2015 May 26;9:191. doi: 10.3389/fncel.2015.00191. eCollection 2015. Review.

9.

Disease-related mutations among Caribbean Hispanics with familial dementia.

Lee JH, Kahn A, Cheng R, Reitz C, Vardarajan B, Lantigua R, Medrano M, Jiménez-Velázquez IZ, Williamson J, Nagy P, Mayeux R.

Mol Genet Genomic Med. 2014 Sep;2(5):430-7. doi: 10.1002/mgg3.85. Epub 2014 Jun 4.

10.

Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study.

Mosconi L, Murray J, Davies M, Williams S, Pirraglia E, Spector N, Tsui WH, Li Y, Butler T, Osorio RS, Glodzik L, Vallabhajosula S, McHugh P, Marmar CR, de Leon MJ.

BMJ Open. 2014 Jun 24;4(6):e004850. doi: 10.1136/bmjopen-2014-004850.

11.

Promise and challenge: the lens model as a biomarker for early diagnosis of Alzheimer's disease.

Tian T, Zhang B, Jia Y, Li Z.

Dis Markers. 2014;2014:826503. doi: 10.1155/2014/826503. Epub 2014 Feb 12. Review.

12.

Association between amylin and amyloid-β peptides in plasma in the context of apolipoprotein E4 allele.

Qiu WQ, Wallack M, Dean M, Liebson E, Mwamburi M, Zhu H.

PLoS One. 2014 Feb 10;9(2):e88063. doi: 10.1371/journal.pone.0088063. eCollection 2014.

13.
14.

Platelets and Alzheimer's disease: Potential of APP as a biomarker.

Evin G, Li QX.

World J Psychiatry. 2012 Dec 22;2(6):102-13. doi: 10.5498/wjp.v2.i6.102. Review.

15.

The prediction of response to galantamine treatment in patients with mild to moderate Alzheimer's disease.

Ohnishi T, Sakiyama Y, Okuri Y, Kimura Y, Sugiyama N, Saito T, Takahashi M, Kobayashi T.

Curr Alzheimer Res. 2014 Feb;11(2):110-8.

16.

Effects of specific multi-nutrient enriched diets on cerebral metabolism, cognition and neuropathology in AβPPswe-PS1dE9 mice.

Jansen D, Zerbi V, Arnoldussen IA, Wiesmann M, Rijpma A, Fang XT, Dederen PJ, Mutsaers MP, Broersen LM, Lütjohann D, Miller M, Joosten LA, Heerschap A, Kiliaan AJ.

PLoS One. 2013 Sep 24;8(9):e75393. doi: 10.1371/journal.pone.0075393. eCollection 2013.

17.

Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.

Amiri H, Saeidi K, Borhani P, Manafirad A, Ghavami M, Zerbi V.

ACS Chem Neurosci. 2013 Nov 20;4(11):1417-29. doi: 10.1021/cn4001582. Epub 2013 Sep 26. Review.

18.

Angiotensin converting enzyme inhibitors and the reduced risk of Alzheimer's disease in the absence of apolipoprotein E4 allele.

Qiu WQ, Mwamburi M, Besser LM, Zhu H, Li H, Wallack M, Phillips L, Qiao L, Budson AE, Stern R, Kowall N.

J Alzheimers Dis. 2013;37(2):421-8. doi: 10.3233/JAD-130716.

19.

Ca2+ influx through store-operated Ca2+ channels reduces Alzheimer disease β-amyloid peptide secretion.

Zeiger W, Vetrivel KS, Buggia-Prévot V, Nguyen PD, Wagner SL, Villereal ML, Thinakaran G.

J Biol Chem. 2013 Sep 13;288(37):26955-66. doi: 10.1074/jbc.M113.473355. Epub 2013 Jul 31.

20.

Hippocampal gene expression meta-analysis identifies aging and age-associated spatial learning impairment (ASLI) genes and pathways.

Uddin RK, Singh SM.

PLoS One. 2013 Jul 18;8(7):e69768. doi: 10.1371/journal.pone.0069768. Print 2013.

Supplemental Content

Support Center